GoAI
Get started
COSMOS Pharmaceutical Corporation logo

COSMOS Pharmaceutical Corporation

3349.T

JPXHealthcareMedical - Pharmaceuticals

Open in GoAI

Latest quote

¥6,412

−¥46.00 · -0.71%

Aug 24, 11:30 AM JST

3349.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

COSMOS Pharmaceutical Corporation manages an extensive network of drugstores throughout Japan. The company operates a significant 1,130 retail locations, strategically positioned across the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. Established in 1983, its primary office is situated in Fukuoka, Japan.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
Headquarters
JP
CEO
Hideaki Yokoyama
Listed since
Nov 11, 2004
Employees
5,709

Market position

Day range

Current ¥6,412

52-week range

Current ¥6,412

Open
¥6,470
Previous close
¥6,458
Volume
103.6K
0.24× average
Average volume
429.2K
Average daily volume
Market cap
508.2B JPY
Beta
0.15
Market reference 1
50-day average
¥6,330.88
+1.28% above average
200-day average
¥6,768.07
-5.26% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
479.12B JPY
P/E (TTM)
15.86×
P/B (TTM)
1.79×
P/S (TTM)
0.46×
EV / EBITDA
7.21×
Earnings yield
6.94%
Free cash flow yield
-2.53%
Dividend yield
1.28%

Profitability & efficiency

Gross margin
20.89%
Operating margin
3.85%
Net margin
2.91%
Return on equity
11.30%
Return on assets
5.37%
Return on invested capital
8.37%

Financial health

Debt / equity
0.28×
Current ratio
0.77×
Altman Z-score
3.6
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends23%16%8%1%Gross margin, FY2022: 20.05%Gross margin, FY2023: 20.38%Gross margin, FY2024: 19.51%Gross margin, FY2025: 21.09%Gross margin, FY2026: 20.89%Operating margin, FY2022: 3.94%Operating margin, FY2023: 3.64%Operating margin, FY2024: 3.26%Operating margin, FY2025: 3.99%Operating margin, FY2026: 3.85%Net margin, FY2022: 3.07%Net margin, FY2023: 2.88%Net margin, FY2024: 2.53%Net margin, FY2025: 3.06%Net margin, FY2026: 2.91%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 20.05%. Gross margin FY2023 20.38%. Gross margin FY2024 19.51%. Gross margin FY2025 21.09%. Gross margin FY2026 20.89%. Operating margin FY2022 3.94%. Operating margin FY2023 3.64%. Operating margin FY2024 3.26%. Operating margin FY2025 3.99%. Operating margin FY2026 3.85%. Net margin FY2022 3.07%. Net margin FY2023 2.88%. Net margin FY2024 2.53%. Net margin FY2025 3.06%. Net margin FY2026 2.91%.

Income trends

Revenue

1.1T JPY+8.72%

Operating income

42.35B JPY+4.82%

Net income

32.05B JPY+3.45%
Income trends across reported periods1.21T JPY776.65B JPY346.08B JPY−84.49B JPYRevenue, FY2022: 755.41B JPYRevenue, FY2023: 827.7B JPYRevenue, FY2024: 964.99B JPYRevenue, FY2025: 1.01T JPYRevenue, FY2026: 1.1T JPYOperating income, FY2022: 29.8B JPYOperating income, FY2023: 30.13B JPYOperating income, FY2024: 31.5B JPYOperating income, FY2025: 40.4B JPYOperating income, FY2026: 42.35B JPYNet income, FY2022: 23.16B JPYNet income, FY2023: 23.8B JPYNet income, FY2024: 24.45B JPYNet income, FY2025: 30.98B JPYNet income, FY2026: 32.05B JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 755.41B JPY. Revenue FY2023 827.7B JPY. Revenue FY2024 964.99B JPY. Revenue FY2025 1.01T JPY. Revenue FY2026 1.1T JPY. Operating income FY2022 29.8B JPY. Operating income FY2023 30.13B JPY. Operating income FY2024 31.5B JPY. Operating income FY2025 40.4B JPY. Operating income FY2026 42.35B JPY. Net income FY2022 23.16B JPY. Net income FY2023 23.8B JPY. Net income FY2024 24.45B JPY. Net income FY2025 30.98B JPY. Net income FY2026 32.05B JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue1.1T JPY1.01T JPY964.99B JPY827.7B JPY755.41B JPY
Cost of goods sold869.9B JPY798.11B JPY776.68B JPY658.98B JPY603.97B JPY
Gross profit229.68B JPY213.28B JPY188.31B JPY168.72B JPY151.45B JPY
Selling, general, and administrative187.33B JPY152.43B JPY138.54B JPY122.81B JPY107.76B JPY
Operating expenses187.33B JPY172.88B JPY156.81B JPY138.59B JPY121.65B JPY
Interest income74M JPY48M JPY44M JPY47M JPY52M JPY
Interest expense581M JPY254M JPY99M JPY51M JPY52M JPY
Depreciation and amortization24.58B JPY22.23B JPY19.92B JPY17.37B JPY15.11B JPY
Operating income42.35B JPY40.4B JPY31.5B JPY30.13B JPY29.8B JPY
Net income32.05B JPY30.98B JPY24.45B JPY23.8B JPY23.16B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
45%
5 beats, 6 misses, 0 met estimates
Average EPS surprise
+4.08%
11 comparable reports
Latest EPS result
117.31
Estimate 119.62 · Miss by 1.93%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates124.4105.3686.3267.28Q1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Jan 10, 2025: actual 79.31, estimate 73.42, surprise +8.02%, Beat. Q2 2025, reported Apr 14, 2025: actual 94.19, estimate 72.06, surprise +30.71%, Beat. Q3 2025, reported Jul 11, 2025: actual 108.95, estimate 112.38, surprise -3.05%, Miss. Q4 2025, reported Oct 14, 2025: actual 105.73, estimate 112.02, surprise -5.62%, Miss. Q1 2026, reported Jan 13, 2026: actual 81.73, estimate 84.01, surprise -2.71%, Miss. Q2 2026, reported Apr 13, 2026: actual 102.2, estimate 102.66, surprise -0.45%, Miss. Q3 2026, reported Jul 13, 2026: actual 117.31, estimate 119.62, surprise -1.93%, Miss. Q4 2026, reported Oct 14, 2026: actual —, estimate 105.98, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates306.53B277.87B249.21B220.55BQ1 '25MissQ2 '25MissQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Jan 10, 2025: actual 244.1B JPY, estimate 245.81B JPY, surprise -0.70%, Miss. Q2 2025, reported Apr 14, 2025: actual 232.34B JPY, estimate 250.08B JPY, surprise -7.09%, Miss. Q3 2025, reported Jul 11, 2025: actual 259.12B JPY, estimate 258.3B JPY, surprise +0.32%, Beat. Q4 2025, reported Oct 14, 2025: actual 279.34B JPY, estimate 274.68B JPY, surprise +1.70%, Beat. Q1 2026, reported Jan 13, 2026: actual 264.78B JPY, estimate 261.84B JPY, surprise +1.12%, Beat. Q2 2026, reported Apr 13, 2026: actual 278.56B JPY, estimate 268.52B JPY, surprise +3.74%, Beat. Q3 2026, reported Jul 13, 2026: actual 294.74B JPY, estimate 286.26B JPY, surprise +2.96%, Beat. Q4 2026, reported Oct 14, 2026: actual —, estimate 292.49B JPY, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥75.00

2025 complete year+122.2% since 2021

2026 partial: ¥44.50

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Nov 27, 2026

¥42.00

Semi-Annual

Record Nov 30, 2026 · Payment Nov 27, 2026

DividendUpcoming

Ex-dividend May 28, 2027

¥42.00

Semi-Annual

Record May 31, 2027 · Payment May 28, 2027

Dividend

Ex-dividend May 28, 2026

¥44.50

Semi-Annual

Record May 31, 2026 · Payment Aug 10, 2026

Dividend

Ex-dividend Nov 27, 2025

¥37.50

Semi-Annual

Record Nov 30, 2025 · Payment Feb 12, 2026

Dividend

Ex-dividend May 29, 2025

¥37.50

Semi-Annual

Record May 31, 2025 · Payment Aug 4, 2025

Dividend

Ex-dividend Nov 28, 2024

¥32.50

Semi-Annual

Record Nov 30, 2024 · Payment Feb 12, 2025

3349.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,008

-0.04%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,799

+0.61%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,990

+0.38%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,392.5

+0.23%

ETFs holding 3349.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
597.37M
Weight
0.02%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥418.5+0.12%
iShares JPX-Nikkei 400 ETF logoiShares JPX-Nikkei 400 ETF1364.T
Market value
171.78M
Weight
0.03%
AUM
592.34B JPY
Expense ratio
0.05%
Price / 1D
¥3,765+0.11%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
22.32M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.71+0.78%
Vanguard FTSE Developed Markets ETF logoVanguard FTSE Developed Markets ETFVEA
Market value
14.82M
Weight
0.00%
AUM
315B USD
Expense ratio
0.03%
Price / 1D
$73.42+0.80%
iShares Core MSCI EAFE ETF logoiShares Core MSCI EAFE ETFIEFA
Market value
10.52M
Weight
0.01%
AUM
195.14B USD
Expense ratio
0.07%
Price / 1D
$100.85+0.86%
Avantis International Small Cap Value ETF logoAvantis International Small Cap Value ETFAVDV
Market value
5.85M
Weight
0.03%
AUM
20.24B USD
Expense ratio
0.36%
Price / 1D
$111.95+1.06%
iShares MSCI EAFE Small-Cap ETF logoiShares MSCI EAFE Small-Cap ETFSCZ
Market value
5.61M
Weight
0.04%
AUM
13.28B USD
Expense ratio
0.40%
Price / 1D
$86.60+0.70%
Schwab International Equity ETF logoSchwab International Equity ETFSCHF
Market value
3.66M
Weight
0.01%
AUM
69.7B USD
Expense ratio
0.03%
Price / 1D
$28.46+0.85%

Continue in GoAI

Research 3349.T

research.disclaimer